Showing results (11-20 of 22) with videos related to
Sort By:
Pageof 3
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|August 31, 2001
Human immunodeficiency virus-seronegative adults with extrapulmonary tuberculosis have abnormal innate immune responsesT R Sterling, S E Dorman, R E Chaisson, et al.The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|July 5, 2007
Alternative anti-tuberculosis regimen including ofloxacin for the treatment of patients with hepatic injuryA Szklo, F C Q Mello, R L Guerra, et al.The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|July 16, 2011
QuantiFERON-TB Gold In-Tube for the detection of Mycobacterium tuberculosis infection in children with household tuberculosis contactT S Kasambira, M Shah, P V Adrian, et al.The Journal of Pediatrics|November 5, 1999
Viral infections in interferon-gamma receptor deficiencyS E Dorman, G Uzel, J Roesler, et al.The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|June 10, 2015
Two-stage activity-safety study of daily rifapentine during intensive phase treatment of pulmonary tuberculosisR Dawson, K Narunsky, D Carman, et al.The Journal of Infectious Diseases|November 7, 1998
Abnormal regulation of interferon-gamma, interleukin-12, and tumor necrosis factor-alpha in human interferon-gamma receptor 1 deficiencyS M Holland, S E Dorman, A Kwon, et al.Clinical Pharmacology and Therapeutics|April 5, 2012
Safety and pharmacokinetics of escalating daily doses of the antituberculosis drug rifapentine in healthy volunteersK E Dooley, E E Bliven-Sizemore, M Weiner, et al.IJTLD Open|October 15, 2025
Diagnostic accuracy of a commercial AI digital stethoscope for diagnosis of TBH Cox, Y Rani, L Nakiyingi, et al.Clinical Pharmacology and Therapeutics|January 27, 2017
Defining the optimal dose of rifapentine for pulmonary tuberculosis: Exposure-response relations from two phase II clinical trialsR M Savic, M Weiner, W R MacKenzie, et al.IJTLD Open|November 17, 2025
Diagnostic accuracy of the Cepheid MTB host response assay for the detection of pulmonary TBY Alkabab, Y Rani, M Farhad, et al.Pageof 3